The Globe and Mail Presents


Biomedical Boom

Leveraging new Canadian growth opportunities


Thursday, November 12, 2020
1:30 P.M. - 3:30 P.M.


Bloom Burton & CO






For years, Canada has been cultivating all the inputs to create a booming biomedical sector. From world-class universities to start-ups to skilled researchers, the industry is poised for large-scale commercialization.

One of the missing elements is investment but 2020 is proving to be a seminal year, with the largest initial public offering for a biomedical company in our nation’s history. The rush to develop COVID-19 tests, treatment and a vaccine is fueling interest in Canadian biotech capabilities. Institutional investors are starting to take notice. What should Canada do now to capture this opportunity? Join The Globe and Mail and Bloom Burton & Co. on November 12, for a discussion among leaders on how to drive growth in Canadian biotech.

Register today to join this FREE webcast on November 12, 2020 from
1:30 PM - 3:30 PM EST






If you have questions for the event speakers, please email and we will try to answer your questions during the live webcast.











Why Bloom Burton & CO? The goal of all investors, companies and organizations is to achieve a monetizing event, such as the ability to raise capital, perform meaningful research and development, license or commercialize products, reach profitability or execute a strategic transaction.

The people who work at Bloom Burton have deep knowledge in medicine, science, patent and corporate law, finance and healthcare invention, development and commercialization.

> Learn more about Bloom Burton & CO.



Market disruption is an accepted reality for business, as new competition and technologies drive the pace of change faster than ever before. Our clients want lawyers who are prepared to lead, differentiate and adapt in a constantly changing world. They want advisers who are curious about the world, and embrace collaboration and candour.

As the original global law firm, we bring the right talent to every client issue, regardless of where the client is. We partner with our clients to deliver solutions in the world's largest economies as well as newly opening markets. We are global citizens, industry savvy, diverse and have a thirst for innovation. Our strength is our ability to adopt a new type of thinking and use cutting-edge legal technologies to help clients overcome the challenges of competing in today's new world economic order.

> Learn more about Baker McKenzie



For general inquiries regarding the Biomedical Boom event, contact The Globe and Mail Events team at .